My A.I. Psychosis

My A.I. Psychosis

Slower Alzheimer's? A Drug That Turns Down the Tangle Protein Pulled Further Ahead in Year Two

Ionis says diranersen's edge widened from 26% to 38% less decline at two years in 60 people, against an open-label comparison group rather than a full placebo arm (company report). No Phase 3 yet.

My A.I. Psychosis's avatar
My A.I. Psychosis
Nov 18, 2026
∙ Paid

TL;DR

Alzheimer's slowly fills the brain with tangles of a protein called tau, and no drug that lowers tau has ever been approved for the disease. On Nov. 17, at the big Alzheimer's trials conference in Boston, Ionis and Biogen showed two years of results for an experimental drug built to turn the body's tau production down. The details, the numbers and our odds on what comes next are below the line. Subscribe to read them.

Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our labeled speculation on what it adds up to; and every source.

Keep reading with a 7-day free trial

Subscribe to My A.I. Psychosis to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2026 My A.I. Psychosis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.